← Ticker index
CHRS
Ticker
CHRS
Congressional Trades
1
by 1 members
Ticker disclosure brief
Congressional disclosure records for CHRS
A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.
Latest receipt
Shri Thanedar
SELL · 2023-01-23
Largest range
$15K – $50K
Shri Thanedar
Longest observed gap
7d
Shri Thanedar
Highest 30d vs SPY
—
No modeled returns
Purchase rows
0
0%
Sale rows
1
100%
Disclosed midpoint
$33K
range estimate
Unique Traders
1
members
Disclosure timing method
Observed filing gaps are not notice-date findings
The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.
Party Breakdown
Democrats1 · 100%
Republicans0 · 0%
Lobbying filings
all →- 2026-05-18$80KCOHERUS BIOSCIENCES INC.Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act, Loans and grants for biologic production Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.
- 2026-04-20$50KCOHERUS BIOSCIENCESIssues related to federal drug reimbursement and domestic manufacturing policy.
- 2026-04-19$60KCOHERUS BIOSCIENCES INCIssues related to domestic manufacturing of pharmaceuticals Federal financial support for the American Biotech Industry Federal Financial Support for the American Biotech Industry
- 2026-03-09$80KCOHERUS BIOSCIENCES INC.Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act, Loans and grants for biologic production Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.
- 2026-01-19$50KCOHERUS BIOSCIENCESIssues related to federal drug reimbursement and domestic manufacturing policy.
- 2026-01-18$60KCOHERUS BIOSCIENCES INCIssues related to domestic manufacturing of pharmaceuticals Federal financial support for the American Biotech Industry Federal Financial Support for the American Biotech Industry
- 2025-10-22$80KCOHERUS BIOSCIENCES INC.Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act, Loans and grants for biologic production Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.
- 2025-10-18$50KCOHERUS BIOSCIENCESIssues related to federal drug reimbursement and domestic manufacturing policy.
- 2025-10-15$50KCOHERUS BIOSCIENCES INCIssues related to domestic manufacturing of pharmaceuticals Federal financial support for the American Biotech Industry Federal Financial Support for the American Biotech Industry
- 2025-08-18$125KCOHERUS BIOSCIENCES INC.Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act, Loans and grants for biologic production Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.
Loading trade analytics…
All Disclosed Trades
Page 1 · 1 of 1 shown| Date | Member | Action | Amount | Observed Gap | Receipt |
|---|---|---|---|---|---|
| 2023-01-23 | DShri Thanedar | SELL | $15K – $50K | 7d | receipt → |
“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.